Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries 4D Molecular Therapeutics Inc (NQ: FDMT ) 15.25 -0.05 (-0.33%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about 4D Molecular Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > Stocks That Hit 52-Week Lows On Thursday December 01, 2022 During Thursday's session, 108 stocks hit new 52-week highs. Via Benzinga Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday November 23, 2022 Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... Via Benzinga Expert Ratings for 4D Molecular Therapeutics November 18, 2022 Via Benzinga 4D Molecular Shares Fall After Filing For Fabry Disease Trial Amendment August 12, 2022 Via Benzinga 4D Molecular Therapeutics to Participate in the Upcoming Evercore ISI HealthCONx 2022 Conference November 21, 2022 From 4D Molecular Therapeutics, Inc. Via GlobeNewswire 2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street November 20, 2022 Recent analyst upgrades suggest these stocks can triple your money or better. Via The Motley Fool HC Wainwright Creates Bullish Pitch On 4D Molecular Citing 'Broader Systemic Potential' November 18, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022 November 18, 2022 Upgrades Via Benzinga Cramer On This Stock Down 65% Year-To-Date: 'I Do Believe It's Bottoming, But I Don't Know What Gets It Higher' November 18, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer said BioXcel Therapeutics Inc (NASDAQ: BTAI) "may be home run or nothing, and that’s always tough." Via Benzinga Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday November 17, 2022 Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. Via Benzinga Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday November 16, 2022 Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. Via Benzinga Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday November 16, 2022 U.S. stocks closed higher on Tuesday, with the Nasdaq Composite gaining more than 150 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session November 15, 2022 Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. Via Benzinga Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected November 15, 2022 U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 15, 2022 Gainers Azenta (NASDAQ:AZTA) shares rose 32.5% to $61.74 during Tuesday's pre-market session. The company's market cap stands at $4.6 billion. As per the news, the Q4 earnings report came out... Via Benzinga 4D Molecular Therapeutics Shares Jump After Early Data From Wet Age-Related Macular Degeneration Trial November 14, 2022 Via Benzinga 4D Molecular Therapeutics Announces Interim Clinical Data from On-going Phase 1/2 Clinical Trial of Intravitreal 4D-150 for Wet Age-Related Macular Degeneration (wet AMD) November 14, 2022 From 4D Molecular Therapeutics, Inc. Via GlobeNewswire Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday November 14, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. Via Benzinga 4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-150 for Wet AMD to be Released Monday, November 14, 2022 November 10, 2022 4D Molecular Therapeutics to host a conference call on November 14th, 8:00 am E.T. From 4D Molecular Therapeutics, Inc. Via GlobeNewswire 4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results November 09, 2022 From 4D Molecular Therapeutics, Inc. Via GlobeNewswire 4D Molecular Therapeutics Announces Interim Clinical Data from Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease at NACFC 2022 November 03, 2022 From 4D Molecular Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session October 27, 2022 Gainers Via Benzinga 4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented at NACFC 2022 October 26, 2022 4D Molecular Therapeutics to host a conference call on November 3rd, 4:30 pm E.T. From 4D Molecular Therapeutics, Inc. Via GlobeNewswire Kiora Pharma is Starting Human Trials of a Novel Treatment That Could Restore Vision In Patients With Inherited Blindness September 29, 2022 Kiora Pharmaceuticals Inc. (NASDAQ: KPRX), a pharmaceutical company specializing in treating eye diseases, is moving its drug candidate KIO-301 into a Phase 1b study in the third quarter of this year. Via Benzinga Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket September 29, 2022 Gainers Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European... Via Benzinga 4D Molecular Therapeutics Appoints Noriyuki Kasahara, MD, PhD to the Board of Directors and Promotes Fred Kamal, PhD to President and Chief Operating Officer September 27, 2022 From 4D Molecular Therapeutics, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022 June 22, 2022 Upgrades Via Benzinga Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday August 15, 2022 Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. Via Benzinga Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session August 12, 2022 Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 August 12, 2022 Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.